Bristol Myers Squibb regains exclusive development and commercialization rights for RayzeBio pipeline products in the Greater China market
王俊杰2017
发表于 어제 11:32
114
0
0
On December 19th, Bristol Myers Squibb announced that the company has reached an agreement with AbbVie Pharmaceuticals to regain exclusive rights to develop and commercialize ABZ-706 (equivalent to RYZ801) in the Greater China market for RayzeBio pipeline products. This pipeline product is used for liver cancer treatment targeting GPC3 targets, and a broad licensing agreement previously signed with AbbVie has been terminated, granting AbbVie the right to develop and commercialize up to four RayzeBio pipeline products (including ABZ-706) in these markets.
CandyLake.com is an information publishing platform and only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
转播
You may like
- Apple's fourth quarter revenue slightly exceeded expectations, but revenue in Greater China fell short of expectations
- Apple's latest announcement! Except for Greater China, they are all growing
- Xu Min, Chairman of Procter&Gamble Greater China: Full of long-term confidence and strategic determination in the Chinese market
- Interview with Mao Yibing, President of Marriott International Greater China: Challenges and Opportunities Parallel in the Chinese Market for 50 Years
- Canada Goose welcomes the peak season; Continued growth in Greater China region
- Canada Goose welcomes peak season and continues to grow in Greater China
- Canadian geese withstand the 'cold wind', sales in Greater China increased by 5.7% in the last quarter
- Interview with Qiu You, Chief Operating Officer of InterContinental Hotels Group Greater China: Deeply cultivating local dual track parallel development
- The revenue growth rate of Greater China region exceeds 50%. Amalfin Sports turned losses in the first three quarters and searched for the next "ancestor bird"
- Revenue in Greater China increased by 56%. Amalfin Sports is fully committed to seizing the growth opportunities of Archaeopteryx and Salomon footwear products
-
"우리는 안전, 깨끗함, 유구한 역사, 인민 우호, 맛있는 음식 등이 외국 관광객들이 중국에 대해 기억하는 고주파 단어라는 것을 조사 연구했다."12월 18일 씨트립그룹은 아랍에미리트 아부다비에서 글로벌 파트너 ...- 月六日尘
- 그저께 09:35
- Up
- Down
- Reply
- Favorite
-
12월 18일, 중국국가약품감독관리국은 EliLillyandCompany (이하"예래"로 략칭함.) 의 알츠하이머병요법을 비준하고 기능달 & amp;reg;(도네 단항 주사액, 4주마다 정맥 주입) 성인이 알츠하이머병으로 인한 경도 ...- 我是来围观的逊
- 3 일전
- Up
- Down
- Reply
- Favorite
-
증권시보에 따르면 골드만삭스는 폭스(FOX) 목표주가를 51달러에서 57달러로 올리고 매수 등급을 유지했다. 여러 기관은 폭스사에 대해 낙관적이다. UBS는 한 보고서에서 기록적인 정치 주기와 강력한 스포츠 경기 ...- 度素告
- 어제 09:27
- Up
- Down
- Reply
- Favorite
-
극월폭뢰 이후 파산이나 경영난에 빠진 자동차 제조 신세력 공장은 위마, 고합, 나타, 극월 등 4개로 바뀌었다. 이 중 두 곳은 모두 바이두가 거금을 들여 투자한 것으로 각각 위마와 극월이다. 초기 투자한 울라이 ...- 空港训港j
- 그저께 20:50
- Up
- Down
- Reply
- Favorite
